STOCK TITAN

Paysign Inc - PAYS STOCK NEWS

Welcome to our dedicated page for Paysign news (Ticker: PAYS), a resource for investors and traders seeking the latest updates and insights on Paysign stock.

Paysign Inc. (PAYS) delivers innovative prepaid card solutions and digital payment services for healthcare, corporate, and government sectors. This news hub provides investors with essential updates on the company’s financial performance and strategic direction.

Access real-time announcements including earnings reports, partnership developments, and product innovations. Our curated collection features regulatory filings, leadership changes, and market expansion updates critical for informed decision-making.

Discover comprehensive coverage of Paysign’s fintech advancements in patient affordability programs and integrated payment processing. Content spans merger activity, technology patents, and compliance updates, maintained for accuracy and relevance.

Bookmark this page for streamlined access to Paysign’s evolving financial narrative. Combine fundamental analysis with timely news to track the company’s position in competitive payment processing markets.

Rhea-AI Summary
Paysign, Inc. (PAYS) announces their first-time sponsorship of the 7th Annual Gene Therapy for Rare Disorders conference. The conference aims to address challenges in gene therapy for rare disorders, with Paysign focusing on patient affordability solutions. Matthew Turner, President of Patient Affordability at Paysign, highlights the company's commitment to improving access to gene therapy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
-
Rhea-AI Summary
Paysign, Inc. (PAYS) sponsors the 2024 ACCESS USA Conference, showcasing their commitment to patient affordability and access in the pharmaceutical industry. The conference combines three key events focusing on industry trends, regulatory reforms, and ethical considerations, providing a platform for industry leaders to exchange ideas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Paysign, Inc. (PAYS) will discuss its fourth quarter and full year 2023 earnings on March 26, 2024, offering insights into its prepaid card programs, patient affordability solutions, digital banking services, and payment processing. The earnings call details are provided for participation and registration for financial professionals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.13%
Tags
conferences earnings
Rhea-AI Summary
PAYS reported a 17% increase in total revenues to $12.4 million in Q3 2023, with a net income of $1.1 million and diluted income per share of $0.02. The company added 19 net new plasma donation centers and launched three new patient affordability programs during the quarter, leading to a 13% increase in plasma revenue and a 142% increase in pharma patient affordability revenue. The company also repurchased 75,000 shares of common stock for $150 thousand, ending the quarter with $9.9 million of unrestricted cash and zero debt.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.53%
Tags
-
Rhea-AI Summary
Paysign, Inc. to discuss third quarter 2023 earnings on November 7, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.58%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.57%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.26%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.5%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.29%
Tags
conferences earnings
Rhea-AI Summary
Paysign completes issuer certification and connection with Mastercard, gaining access to a robust global network. The collaboration brings enhanced security, innovative solutions, and seamless integration, strengthening Paysign's position in the market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Paysign Inc

Nasdaq:PAYS

PAYS Rankings

PAYS Stock Data

116.09M
33.90M
37.81%
35.88%
1.07%
Software - Infrastructure
Services-business Services, Nec
Link
United States
HENDERSON